EC Healthcare's position of paying dividends despite reporting losses over the last year is worrying. However, dividends have been adequately covered by free cash flow. These factors could potentially result in sub-optimal outcomes for dividend investors.

EC Healthcare's weak revenue projection and low price-to-sales ratio hint that shareholders may face sluggish share price growth. Despite strong past earnings, the future may not be as promising leading to recent share price drop.

The 47% share price fall isn't as bad as the EPS reduction, hinting towards possible recovery optimism reflected in a P/E of 45.09. Unresolved challenges may still persist, inferred from last year's performance surpassing a 5% half-decade loss.